News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syntagon Restructures to Further Improve Drug Substance Development Offering


12/22/2011 6:35:48 AM

STOCKHOLM--(BUSINESS WIRE)--Syntagon’s Sweden-based operations (Syntagon AB) will focus and strengthen its customer-oriented expertise within drug substance development, quality assurance and regulatory support, while the Group’s Latvian site (SIA Syntagon Baltic) will ramp up its capacity and know-how within the field of preclinical and clinical deliveries of drug substances.

Read at BioSpace.com

comments powered by Disqus
Syntagon
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES